Navigation Links
Siemens Completes Acquisition of Dade Behring
Date:11/6/2007

Complementing business of Siemens Medical Solutions Diagnostics

ERLANGEN, Germany, Nov. 6 /PRNewswire-FirstCall/ -- Siemens has successfully completed the acquisition of Dade Behring Holdings, Inc. The laboratory diagnostics company joins the existing business of Siemens Medical Solutions Diagnostics. As the market leader in the attractive and rapidly growing field of in vitro diagnostics, Siemens now can offer its customers a unique and comprehensive healthcare solutions' portfolio, which brings together the entire medical imaging, laboratory diagnostics and clinical information technology (IT) value chain under one roof.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"The acquisition of Dade Behring, which holds a strong position in clinical chemistry, ideally complements our acquisitions of Diagnostic Products Corporation and Bayer Diagnostics," explained Erich R. Reinhardt, member of the Managing Board of Siemens AG and President and CEO of Siemens Medical Solutions. "The implementation of integrated IT and clinical solutions from Siemens will help improve workflow efficiency throughout the healthcare enterprise, from admissions and administration, to the laboratory and the radiology department. This will enable our customers to increase the quality of patient care while simultaneously reducing costs," Reinhardt added.

As the first and only global fully integrated diagnostics company, Siemens Medical Solutions is in a unique position to leverage trendsetting solutions across the entire healthcare continuum - from prevention to diagnosis, to therapy and care.

Siemens (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and ta
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
2. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
3. Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
4. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Carrington Completes $8 Million Financing
8. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
9. New Brunswick Scientific Completes Merger Transaction with Eppendorf
10. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
11. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...v. 9 BioMed Realty Trust...any has received commitments from lenders to incre...f credit by $65 million to an aggregate of $665 mi...acility. The weighted-average effective interest ...of September 30, 2009. The maturity date remains A...
(Date:11/9/2009)...Nov. 9 CEL-SCI Corporati...neth S. Rosenthal, Professor of Immunology and Mic...e of Medicine and Pharmacy, reported on work condu...land Clinic and CEL-SCI on CEL-SCI,s LEAPS vaccine...Cbio Vaccine: "All Things Considered" Conference i...
(Date:11/8/2009)... As global temperatures and energy costs continue ...o a sustainable future. An attractive replacemen...ished online in Genome Research ( www.genome.org... of bioethanol-producing microorganisms, uncoverin...g new technologies needed to implement production ...
(Date:11/6/2009)...., Nov. 6 BioSpecifics T...tical company developing first-in-class collagenas...sults for the third quarter ended September 30, 20...mber of this year, the FDA,s Arthritis Advisory Co..., the approval of XIAFLEX(TM) for the treatment of...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...-Aldrich (Nasdaq: SIAL ), has released its new "...g. The catalog features more than 4,000 products ...onics, Metal & Ceramic Science,Nanomaterials, ...hapter,contains technical information and highligh...s. , "This catalog serves as a materials sup...
...Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: ...suit in U.S. District Court in Delaware against My...n, Inc., and Barr,Pharmaceuticals, Inc. and its su...t of Eurand,s U.S. Patent Number 7,387,793. This ...ning the muscle relaxant cyclobenzaprine,including...
...l Center,has earned the Joint Commission,s Gold Se...ith the Joint Commission,s national standards for ...dical Center has been awarded its full,accreditati...nounced, initial on-site evaluation,of Shasta Regi...th, 2008.,Following a rigorous survey, the Joint C...
Other Biology Technology:Aldrich(R) Releases Materials Science Catalog That Includes Products to Advance Sustainable Energy and Nanotechnology Research 2Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 2Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 3Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 4Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals 5Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 2Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission 3
(Date:11/4/2009)...s out, hold the power to help militaries and munit...p toxic waste on test sites. , Compounds known a... in World War II and have been used in military mu...are often used to propel tank shells and act like ...reased knowledge of their environmentally harmful ...
(Date:11/4/2009)...s received more than $10 million in research grant...l stimulus program, bringing thetotal amount of st...illion. Thirty-three projects achieved stimulus f...ther. , "The university has thoughtfully underta...larly excellence to federal agency priorities. Th...
(Date:11/4/2009)...FirstCall/ -- Quest Diagnostics Incorporated (NYSE...ic testing, information and services, announced th... income from continuing operations rose to $192 mi...on, or $0.81 per diluted share, for the third quar...educed by a $0.03 per share charge associated with...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 1Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 2Octapharma Group and Fresenius Kabi Enter Into an Exclusive License Development and Supply Agreement for a HESylated Recombinant Protein 5787 3INFORMS presents 11 new Fellows Awards 60247 1INFORMS presents 11 new Fellows Awards 60247 2EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 1EPAs new green parking lot allows scientists to study permeable surfaces that may help the environment 10560 2
...e-eclampsia in the early stages is being trialed i...try & Industry, the magazine of the SCI. The t...low mums-to-be to check for themselves whether the...omless in the early stages but kills 1000 babies i...re reliable than the traditional blood pressure an...
...ologists have put out a call for teeth tusks, femu... left by massive Ice Age floods in southeastern Wa...tons of Mammathus columbi, the Columbian mammoth, ...e Yakima, Columbia and Walla Walla valleys in sout... came to rest as water receded from the temporary ...
...nia, San Diego (UCSD) School of Medicine have deve...cs ?the large-scale study of the structure and fun... them to map an extensive network of the signaling...rk, providing the first comprehensive profile of c... of cell migration in cancer metastasis and inflam...
Other Biology News:Simple home spit test to spot deadly pre-eclampsia 2An ancient bathtub ring of mammoth fossils 2How to steer a moving cell 2How to steer a moving cell 3
Custom Production Service - Quality from AbD Serotec
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
...ptide Synthesis , 20 Amino Acid length max , MS... to customer for future usage conjugation of pepti... 102 days/each , Pre-immune bleed x1 /each , ...t bleed (app. 5 ml) x1 /each , Production blee...
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
Biology Products: